Abnormal activation of TGF-β1 in the late stages of gastric cancer has been revealed to promote the development of aggressive growth and metastases of primary gastric carcinomas by regulating paracrine effects on mesenchymal cells, vascular endothelial cells, and lymphocytes [16]. This evidence concerns the gene TGFB1 and gastric cancer.